Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Provention Bio
Biotech
Provention snags $60M to prep for diabetes drug launch
Provention Bio may be waiting a bit longer for the FDA's decision on its diabetes drug, but at least they have $60 million cash in the meantime.
Gabrielle Masson
Jul 8, 2022 10:52am
FDA delays review of Provention Bio's embattled diabetes drug
Jun 30, 2022 7:21pm
Provention med for delaying diabetes clear for FDA resubmission
Jan 27, 2022 4:54pm
Provention hires 3rd exec as it awaits FDA meeting for lead drug
Nov 17, 2021 10:31am
Provention Bio hires early research exec from Gossamer
Nov 8, 2021 7:05am
Provention will wait for FDA to 'opine' on new teplizumab data
Sep 13, 2021 10:25am